Broad growth for AFT Pharma

Jan 15, 2026 | Latest News

15.1.26 AFT Pharmaceutical are seeing broad-based growth across operations, and are putting additional projects in place to support our drive towards the FY 7 $300 million revenue target. “We also reiterate that we remain on track to deliver FY 26 operating earnings of $20 million to $24 million,” said managing director Dr Hartley Atkinson. AFT […]

You need an active membership to keep reading

either log in via the form below or click here to subscribe

If you have recently subscribed and selected to pay by bank transfer our admin team will activate your membership once payment has cleared

[adrotate banner="4"]

Broad growth for AFT Pharma

You need an active membership to keep reading

either log in via the form below or click here to subscribe

Your Advertisement Here

Your Advertisement Here